Molecular therapies and precision medicine for hepatocellular carcinoma
Molecular therapies and precision medicine for hepatocellular carcinomaMolecular therapies and precision medicine for hepatocellular carcinoma, Published online: 30 July 2018; doi:10.1038/s41571-018-0073-4Molecular profiling studies are providing novel insights into the biology of hepatocellular carcinoma, although these remain to be translated into novel effective therapies. Nevertheless, therapeutic advances have been made in the past few years, and further advancements are expected in the near future, including biomarker-driven treatments and immunotherapies, as discussed in this Review.
Source: Nature Clinical Practice Oncology - Category: Cancer & Oncology Authors: Josep M. Llovet Robert Montal Daniela Sia Richard S. Finn Source Type: research
More News: Biology | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Immunotherapy | Liver Cancer | Molecular Biology | Study